ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
10 hedge funds and large institutions have $766K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$362K | |
| 2 | +$145K | |
| 3 | +$126K | |
| 4 |
Morgan Stanley
New York
|
+$15K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.8K |
Top Sellers
| 1 | -$36K | |
| 2 | -$34K | |
| 3 | -$22K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$16K |
| 5 |
HF
HRT Financial
New York
|
-$10K |